Literature DB >> 30100071

Autoimmune diseases after hepatitis B immunization in adults: Literature review and meta-analysis, with reference to 'autoimmune/autoinflammatory syndrome induced by adjuvants' (ASIA).

J Mark Elwood1, Rohan Ameratunga2.   

Abstract

BACKGROUND: To assess if hepatitis B vaccination in adults is causally associated with autoimmune diseases. Such causation has been claimed based mainly on case reports and uncontrolled studies, and a syndrome 'Autoimmune/autoinflammatory Disorder Induced by Adjuvants' (ASIA) has been claimed to be linked to immunization, particularly hepatitis B vaccination.
METHODS: Review of peer-reviewed literature from January 1990 to March 2017 identifying controlled studies with documented incidence of autoimmune diseases occurring after hepatitis B vaccinations in adults. From 1297 studies identified, 259 were further assessed and 49 reviewed further; 19 relevant papers reporting 21 results are reviewed here, and 14 results included in a meta-analysis.
RESULTS: Overall no association between hepatitis B vaccination and the onset of autoimmune diseases was seen. The overall odds ratio was 1.06, with 95% confidence limits of 0.93-1.21, with non-significant heterogeneity. Only one study showed a significant excess risk between hepatitis B immunisation and autoimmune disease.
CONCLUSIONS: Despite multiple case reports, there is no reliable scientific evidence of autoimmune diseases being caused by hepatitis B vaccinations.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ASIA syndrome; Autoimmune disease; Case-control study; Cohort study; Hepatitis B; Meta-analysis; New Zealand; Vaccination

Mesh:

Substances:

Year:  2018        PMID: 30100071     DOI: 10.1016/j.vaccine.2018.07.074

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  5 in total

Review 1.  An Overview of Vaccine Adjuvants: Current Evidence and Future Perspectives.

Authors:  Alessio Facciolà; Giuseppa Visalli; Antonio Laganà; Angela Di Pietro
Journal:  Vaccines (Basel)       Date:  2022-05-22

Review 2.  Vaccine safety issues at the turn of the 21st century.

Authors:  Laura Conklin; Anders Hviid; Walter A Orenstein; Andrew J Pollard; Melinda Wharton; Patrick Zuber
Journal:  BMJ Glob Health       Date:  2021-05

Review 3.  EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients.

Authors:  Markus Cornberg; Maria Buti; Christiane S Eberhardt; Paolo Antonio Grossi; Daniel Shouval
Journal:  J Hepatol       Date:  2021-02-06       Impact factor: 25.083

4.  Perspective: the nose and the stomach play a critical role in the NZACE2-Pātari* (modified ACE2) drug treatment project of SARS-CoV-2 infection.

Authors:  Rohan Ameratunga; See-Tarn Woon; Richard Steele; Russell Snell; Natalie Medlicott; Emily Mears; Euphemia Leung; Klaus Lehnert; Anthony Jordan; Shyamal Das; William Abbott; Hilary Longhurst; Miguel E Quiñones-Mateu
Journal:  Expert Rev Clin Immunol       Date:  2021-05-14       Impact factor: 4.473

5.  Safety of Multiple Vaccinations and Durability of Vaccine-Induced Antibodies in an Italian Military Cohort 5 Years after Immunization.

Authors:  Claudia Ferlito; Vincenzo Visco; Roberto Biselli; Maria Sofia Cattaruzza; Giulia Carreras; Gerardo Salerno; Florigio Lista; Maria Rosaria Capobianchi; Concetta Castilletti; Daniele Lapa; Guido Antonelli; Massimo Gentile; Maurizio Sorice; Gloria Riitano; Giuseppe Lucania; Valeria Riccieri; Fabrizio Mainiero; Antonio Angeloni; Marco Lucarelli; Giampiero Ferraguti; Alberto Autore; Marco Lastilla; Simonetta Salemi; Michela Ileen Biondo; Andrea Picchianti-Diamanti; Sara Caporuscio; Raffaela Teloni; Sabrina Mariotti; Roberto Nisini; Raffaele D'Amelio
Journal:  Biomedicines       Date:  2021-12-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.